VALENCIA, Calif.--(BUSINESS WIRE)--Advanced Bionics (AB), a global leader in cochlear implant technology and a company of the Sonova Group, announced today that the Naída CI Q30 and Q90 sound processors* have been approved by the Food and Drug Administration for distribution in the United States. FDA approval follows Health Canada approval earlier this year. Wide distribution of the Naída CI Q90 in the United States and Canada is planned to take place later this year. The Naída CI Q30 is designed to meet the needs of the global market and will be available in specific markets outside of North America. The latest version of AB’s signature fitting software, SoundWave™ 2.3, also received approval.
Working with Phonak, the world leader in hearing instruments, AB provides industry-leading solutions to help people with significant hearing loss communicate with confidence. The Naída CI Q Series sound processors combine AB’s proven innovations with popular Phonak features relied on by hundreds of thousands of hearing aid users for better hearing in all situations. With technology designed to automatically adjust to different sound environments, reduce distracting noise for unilateral and bilateral recipients, maximize hearing comfort, and offer waterproof protection, Naída CI Q Series sound processors offer a range of options to suit every recipients’ lifestyle and hearing needs. Also new to the Q Series are PowerCel™ innovations that reduce size and improve battery life.
“AB and Phonak have a truly unique relationship where we work side by side combining our talents and technologies to deliver innovations never before seen in this industry,” said Hansjuerg Emch, President of Advanced Bionics and Group Vice President of the Sonova Medical Division where AB resides. “The Q Series is the result of two organizations working together as one united team with the same goal, which is to improve lives by developing the world’s best hearing solutions.”
The Naída CI Q90 is the top-of-the-line processor in the Naída CI Q Series from Advanced Bionics, following the previous release of the Naída CI Q70, which raised the bar for superior hearing. Offering new microphone technology for focusing on speech, the Naída CI Q90 now surpasses the bar as the premium choice for recipients who want the full line of features.
New and current Naída CI Q70 recipients** can also benefit from some of the advanced new Q Series features, including new innovations that automatically reduce obtrusive sounds, such as wind, echoes, and sudden loud noises to improve hearing in difficult environments.
The Naída CI Q30 sets the bar for the Q Series family, offering proven AB and Phonak technology that lead the industry for hearing in noise and the option of the smallest PowerCel battery to date, compatible with all Q Series processors.
Available for the Naída CI Q70 and Q90 sound processors, Phonak Binaural VoiceStream Technology™ gives two Naída CI processors the unique ability to work together for improved hearing in challenging situations. Sound from one side is transmitted to the other side so that recipients hear the sound in both ears at the same time while distracting noise is reduced. No other manufacturer can offer the extraordinary binaural benefits this technology provides for effortless communication.
The only sound processor family that delivers hearing as unique as you are, the Q Series provides state-of-the-art technology designed to help recipients communicate with confidence, enjoy music, and stay connected to the latest consumer electronics.
- Proven technologies for better speech understanding
- Automatic adjustments for any environment
- Superior advancements for hearing in noise, on the phone, and in water
- The broadest and most proven portfolio of wireless connectivity accessories, including the new Phonak EasyCall accessory and Phonak DECT Phone
- Groundbreaking innovations in maximizing hearing with two ears working together
The latest version of SoundWave, AB’s signature fitting software, will soon be available to clinicians for enabling the new features.
About Advanced Bionics
Advanced Bionics is a global leader in developing the most advanced cochlear implant systems in the world. Founded in 1993 and a subsidiary of the Sonova Group since 2009, AB develops cutting-edge cochlear implant technology that allows recipients to hear their best.
AB offers the most sophisticated cochlear implant system on the market, the HiResolution™ Bionic Ear System, with five times more sound resolution than its competitors, designed to help recipients hear in noisy settings and enjoy the full dimensions of music and tonal languages.
With sales in over 50 countries and a proven track record for developing high-performing, state-of-the-art products, AB’s talented group of technologists and professionals from all over the world are driven to succeed, work with integrity and stay firmly committed to quality.
To learn more about AB and its innovative cochlear implant technology, please visit AdvancedBionics.com.
*Not all products listed are available in all territories and not all features are available in all devices.
**Software upgrade required